Navigation Links
Increase in renal problems

The cognitive problems that can occur in patients with chronic renal failure might be alleviated by certain antioxidants, say US researchers. Scientists at the University of California, Irvine, found that rodent models of chronic renal failure had higher levels of nitrotyrosine,// a marker of oxidative damage caused by the interaction of oxygen free radicals with nitric oxide, in areas of their cerebral cortex than healthy control rats.

However, by treating the rats with kidney failure with an antioxidant called des-methyl-tirilizad, the scientists were able to lower the levels of molecules responsible for the oxidative stress. “This study shows how free radicals and nitric oxide interact to produce oxidative stress and help cause these neurological dysfunctions,” said Dr Nick Vaziri, head of the research. “It also may provide a way to treat these disorders,” he said.

Dr Vaziri suggested that it might be possible to link the results with similar events that occur in the nervous system in other disorders, such as in Huntington’s and Alzheimer’s disease. “However, more studies are needed to determine if this could be useful in humans,” he said.

The researchers are hopeful that antioxidants might be used in the future to treat, or even to prevent, cognitive dysfunction. An estimated 100,000 people in the UK suffer from some form of kidney disease, excluding cystitis and kidney stones, with renal failure leading to about 7,000 deaths in the UK each year.

'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Increase in sugar...decrease in brain function!!!
3. Increase in tobacco deaths
4. Increased Heart Attack Risk From Celebrex,Vioxx
5. Deep Sleep Doesnt Increase Memory
6. Allergy Risk Increased by Kerosene Use
7. IVF technique May Increase The Risk Of Birth Defects
8. Step Aerobics Increases good cholesterol
9. Fewer teeth & Increased Ischemic Stroke risk
10. Painkillers Increase Risk of Miscarriage
11. Diabetes on the Increase but Death Rate Falling
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Increase renal problems

(Date:11/21/2008)... LOS ANGELES, Nov. 21 In a recent ... broadening the Sales and Use Tax to include,"lux...ure to cause an increase,in animal shelter overpo...te,are joining forces and urging all pet owners t...legislature to stop this tax. , "Our compan...
(Date:11/21/2008)... Winter viruses may be to blame, study suggests ,...he season of a baby,s birth may help predict that ..., Babies born in autumn -- about four months befor... 30 percent increased risk of asthma compared to b...tudy in the first December issue of the American ...
(Date:11/21/2008)... ROCKVILLE, Md., Nov. 21 /PRNewswire-USNewswire/ -... has issued a final rule for Patient Safety Organi...tive on Jan. 19, 2009. It provides final requireme...ich clinicians and health care providers can work ...legally secure environment of privilege and confid...
(Date:11/21/2008)... DALLAS, Nov. 21 Anita Picozzi Mor... Ms. Moran, nationally recognized for her work in ...Education, Science and Technology practice and bro... , , "Anita,s experience and skills comp...ies with our college and university clients," said...
Breaking Medicine News(10 mins):Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3Health News:Autumn Babies More Prone to Asthma 2Health News:Autumn Babies More Prone to Asthma 3Health News:Final Rule Issued for Patient Safety Organizations 2Health News:Final Rule Issued for Patient Safety Organizations 3Health News:Anita Moran AIA Joins WHR Dallas 2
...y may reduce the risk of kidney failure in men.// ...ad moderate consumption of alcohol weekly (about a...ne levels and reduced glomerular filtration rates ... day of alcohol. The research had moderated the dr...
...been associated to cardiovascular diseases and rec...ronary artery aneurysms. Studies have always been ...se on the health of the person. The new study was ...f cocaine abuse on the health of the heart. In co...
... to cause acute deficiency of immunity in man, a d... that a part of the body’s immunity system can and..., which has come out in the journal Nature Medicin...tibodies are successful in fighting and stalling t...
...dings of a recent study researchers say cholestero...es and keep cells healthy , however researchers al...being warehoused inside the arteries, where it bui...acks and strokes. Researchers suggest an enzyme ca...
Other Medicine News:
(Date:11/20/2008)... Nov. 20 GlaxoSmithKline ...tes Food and Drug Administration (FDA) granted acc...r the treatment of thrombocytopenia in patients wi...rpura (ITP) who have had an insufficient response .... The approval is a significant milestone for PROM...
(Date:11/20/2008)...re-FirstCall/ -- Bionovo, Inc.,(Nasdaq: BNVI ) ...e Phase 1B,clinical trial of their lead drug cand...01, at the Society for Integrative Oncology,s Fift...The Company,s oral presentation was selected,as a...art of the Best of the,SIO Session on November 20...
(Date:11/20/2008).../ -- PAREXEL International Corporation (Nasdaq: ...s provider, today announced that it has opened an ...ing and clinical research capabilities. With the a...ons throughout five important biopharmaceutical ce...na, Brazil, Chile, and Mexico. This expansion furt...
(Date:11/19/2008)...tistical significance , , ISELIN, N.J., Nov...n (Nasdaq: PARS ) today announced results from i...sion (NE) drug delivery technology formulated with...i-center, randomized, double-blinded, placebo-cont...the Company,s 3% Diclofenac Diethanolamine NanoEmu...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Medco Announces Organizational Changes 26817 1Medco Announces Organizational Changes 26817 2Medco Announces Organizational Changes 26817 3Giant Food Alerts Customers to Voluntary Recall of Grandma Taylors Gourmet Dipping Cookies Sold in Giant Stores 26814 1Dynatronics to Release Fourth Quarter and Year end Results Monday September 29 2008 3B Conference Call Set for 3 3A00 p m ET 26811 1Dallas Charla Aldous Earns Trial Lawyer of the Year Award 26808 1Dallas Charla Aldous Earns Trial Lawyer of the Year Award 26808 2
...Chi-Med, the Hutchison Whampoa backed pharmaceutic...results for its Phase II,proof-of-concept study fo... a form of inflammatory bowel disease. The trial ...ted and showed an,equivalent drop in clinical symp...current first-line standard of care in,mild-to-mod...
...CeNeS Pharmaceuticals (AIM:CEN),("CeNeS" or "the C...pany today announced that a paper published this w...s that a,catechol-O-methyltransferase (COMT) inhib...t to address profound cognitive,deficits in schizo... discovery programme to develop novel COMT inhibit...
Other Medicine Technology:Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 2Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 3Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 4
... antigen (PSA) is a serine protease that is found ...f the acini and ducts. Normal PSA concentration in...ve suggested that elevated level of whole blood or...gnosis of prostate cancers. InstaTest PSA is desig...
The IDS Gamma-B 25-Hydroxy Vitamin D kit is a conventional liquid phase radioimmunoassay intended for the quantitative determination of 25-hydroxy vitamin D (25-OHD) and other hydroxylated metabolite
A complete workstation for haemostasis , A compact and convenient analyser , A comprehensive system , An exellent reliability: the STAGO patented detection mode
...MPD Lancets are designed with Shallow Point Comfor... thin gauge needle with its shallow-angled edges a...etration without tearing the skin. The unique plas...tients with arthritis or weak fingers. MPD Lancets...
Medicine Products: